Please login to the form below
Sigma-Aldrich
This page shows the latest Sigma-Aldrich news and features for those working in and with pharma, biotech and healthcare.
Merck mulls sale of consumer health division
strategy. It's been bulking up of late in some areas - including research tools with its recent purchases of Sigma-Aldrich and Millipore - and jettisoning others including biosimilars.
Latest news
-
Avelumab costs peg back profit at Merck KGaA
of Sigma-Aldrich.
-
Merck's pharma unit faces tougher 2017 as fertility boost recedes
Overall, Merck reported 19% group sales growth to 3.7bn - driven largely by its acquisition of chemicals business Sigma-Aldrich - and the company has raised its earnings forecasts for the year.
-
Merck makes $17bn play for Sigma-Aldrich
Germany's Merck KGaA has cut a deal to buy US lab supply business Sigma-Aldrich for $17bn in a move that reduces the significance of its pharmaceuticals arm to the ... Sigma-Aldrich is Merck's biggest acquisition to date - eclipsing its $13.5bn
More from news
Approximately 1 fully matching, plus 3 partially matching documents found.
Latest Intelligence
-
Deal Watch table for September 2014
Sigma Aldrich / Merck KGaA. Company acquisition. Laboratory supplies. 17, 000.
-
Pharma deals during September 2014
It has announced the purchase of Sigma Aldrich for $17bn representing a hefty 6.3x sales. ... Merck Group comprises biopharmaceutical (2013 sales $7.7bn), consumer health ($0.6bn), performance materials ($2.1bn) and laboratory supplies ($3.4bn $2.7bn
More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest appointments
-
Bedrock appoints new commercial director
Dr Laura Ciccolini brings experience from the Biopharm Group and Sigma Aldrich. ... She has over 15 years experience in life sciences and biochemical engineering and previously served as a business development manager for chemical, life science and
-
Eric Rhodes becomes CEO of ERS Genomics
Prior to joining Horizon Discovery, Rhodes held a number of senior positions including director of business development at Sigma-Aldrich and vice president of business development and alliance management at Sangamo
-
Merck appoints head of combined life science business
Batra has been CEO and president of Merck Millipore since March 2014 and will, alongside Sigma-Aldrich president and CEO Rakesh Sachdev, will continue to run both organisations independently leading up ... Karl-Ludwig Kley, chairman of the executive
-
Horizon Discovery appoints executive director
company.”. His previous roles include the position of CEO at Sage Labs, chief scientific officer of Sigma-Aldrich and president of its research biotechnology business unit.
More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Exciting Medical Writer Career Opportunity for Postdoc, Medcomms
-
Highly competitive salary
- Lead Market Access Writer, £5K joining bonus, UK
-
Highly competitive salary
- Principal Medical Writer/ Scientific Lead, Medcomms, £5K joining...
-
Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
-
Highly competitive salary
- World Health Organization releases latest set of COVID-19 guidelines
- Europe’s cancer community publishes new report on transforming patient care
- BeiGene’s Brukinsa receives FDA approval for chronic lymphocytic leukaemia
- AstraZeneca/Daiichi Sankyo’s Enhertu approved by EC for advanced breast cancer
- Eli Lilly announces $450m investment in US manufacturing site
- EU outlines measures to mitigate antibiotic shortage across Europe
- Innovative Trials comments on extra funding to increase access to clinical trials for cancer patients
- Gilead’s CAR-T cell therapy recommended by NICE for lymphoma
- JCVI recommends autumn COVID-19 vaccine booster for those at highest risk
- MIT researchers develop AI model to detect future lung cancer risk
- Merging global and local pharmacovigilance operations into a successful integrated approach
- Diversifying Healthcare AI with Federated Learning
- FDA and CDC investigate potential safety concern for Pfizer/BioNTech’s COVID-19 vaccine
- World Health Organization releases latest set of COVID-19 guidelines
- AbbVie and Eli Lilly leave UK’s voluntary drug pricing agreement
- AbbVie trial backs chemo-free Imbruvica combo regimen
- AstraZeneca/Daiichi Sankyo’s Enhertu approved by EC for advanced breast cancer
- EU to revise pharmaceuticals law amid antibiotic shortages
PMHub
Blue Latitude Health
Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...
Latest intelligence
- Virtual Steering Committee & Peer Influence Program
- In this customer story, we describe the methodology and results of our client’s ongoing Virtual Steering Committee & Peer Influence program....
- Meeting healthcare’s rising challenges
- The journey to discover novel therapies through digital innovation and ensure scientific advances achieve their potential...
- Report gives insights to address gaps in HCP engagement
- How does Pharma-HCP engagement need to evolve in today's digital landscape?...
